Movement restrictions, supply chain disruptions and reduced health facility services associated with the COVID-19 pandemic are affecting women’s and adolescent girls’ sexual and reproductive health and rights (SRHR) needs, including access to safe abortion services. Self-managed medication abortion (MA) in early pregnancy is an established practice which has become increasingly important in response to COVID-19. As the Foreign, Commonwealth and Development Office (FCDO) Women’s Integrated Sexual Health (WISH) programme partners adapt their programmes to continue service provision during COVID-19, this Learning Brief summarises relevant learning from WISH partners and members of the wider SRHR community on self-managed medication abortion approaches during the pandemic. It is written by WISH4Results, the Third-Party Monitoring team for the FCDO WISH Programme.

Read the full learning brief here.